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Abstract
Background: VE-cadherin is the chief constituent of endothelial adherens junctions. However, the role of
VE-cadherin in the pathogenesis of cerebrovascular diseases including brain ischemia has not yet been
investigated.
Methods: VE-cadherin heterozygous (VEC+/-) mice and wildtype controls were subjected to transient brain
ischemia by 30 min filamentous middle cerebral artery occlusion (MCAo)/reperfusion.
Results: Acute lesion sizes as assessed by MR-imaging on day 3 did not differ between genotypes. Unexpectedly,
however, partial loss of VE-cadherin resulted in long-term stroke protection measured histologically on day 28. Equally
surprisingly, VEC+/- mice displayed no differences in post-stroke angiogenesis compared to littermate controls, but
showed increased absolute regional cerebral blood flow in ischemic striatum at four weeks. The early induction of
VE-cadherin mRNA transcription after stroke was reduced in VEC+/- mice. By contrast, N-cadherin and β-catenin mRNA
expression showed a delayed, but sustained, upregulation up to 28 days after MCAo, which was increased in VEC+/-
mice. Furthermore, partial loss of VE-cadherin resulted in a pattern of elevated ischemia-triggered mRNA transcription
of pericyte-related molecules α-smooth muscle actin (α-SMA), aminopeptidase N (CD13), and platelet-derived growth
factor receptor β (PDGFR-β).
Conclusions: Partial loss of VE-cadherin results in long term stroke protection. On the cellular and molecular
level, this effect appears to be mediated by improved endothelial/pericyte interactions and the resultant
increase in cerebral blood flow. Our study reinforces accumulating evidence that long-term stroke outcome
depends critically on vascular mechanisms.
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Background
The concept of the neurovascular unit is proving to be very
useful in efforts to elucidate the pathobiology of stroke [1].
Brain ischemia is a vascular disorder affecting neuronal
function. Indeed, the biological effects of ischemia are not
confined to neurons, but impact an ensemble of different
cell types in the brain, which, together, form the neurovas-
cular unit. The bimodal response of the neurovascular unit
to stroke is characterized by blood-brain-barrier disruption
followed later by vascular remodeling and, hence, the
switch from brain injury to repair and recovery.
Endothelia form a critical component of the neurovas-
cular unit. Junctional proteins mediating homotypic inter-
endothelial cell-cell contacts or heterotypic interactions
with perivascular cells shape endothelial cell behavior [2].
VE-cadherin is the chief constituent of adherens junctions.
Expression of VE-cadherin is strictly confined to endothe-
lia [3]. By contrast, N-cadherin, the second major endo-
thelial cadherin, is also expressed by other cells including
neurons [4], astrocytes [5], and pericytes [6].
So far, surprisingly little experimentation has been done
on the role of junctional proteins in cerebrovascular dis-
ease. Importantly, the primary focus of this research has
been on acute blood-brain barrier protection and mainten-
ance of vascular integrity (e.g. [7–9]). However, a number
of studies conducted both in human stroke patients and in
experimental rodents have demonstrated that acute lesion
size is a poor predictor of overall stroke outcome [10]. It
should also be noted that endothelial junctional proteins
represent interesting candidates for further research
because they are potentially druggable (e.g. [11, 12]).
In the current study, we investigated the effects of par-
tial loss of VE-cadherin in VEC+/- mice on both acute
and chronic stroke outcome. Acute stroke outcome did
not differ between VEC+/- mice and controls. However,
chronic lesion sizes were significantly reduced in VEC+/-
animals. This was associated with an increase in the
overall pattern of mRNA transcription of other junc-
tional proteins and pericyte-related molecules in VEC+/-
mice. Taken together, our results suggest that junctional
proteins may be harnessed to promote blood flow and
recovery after stroke.
Methods
Animals and drug treatment
Young adult (12-16 weeks old) male VEC+/- mice and lit-
termate controls were provided by IFOM, Milan, Italy. The
generation of these mice has been described previously
[13]. The VEC+/- mice were maintained on a mixed genetic
background of 129SVJ and CD1 strains [14]. Measure-
ments of body weight before the MCAo procedure were as
follows [mean ± S.E.M., range]: VEC+/+, 40.8 ± 0.6 g, 33.2 -
48.8 g; VEC+/-, 40.3 ± 0.4 g, 35.6 - 45.7 g. Animals were
kept under specific pathogen free (SPF) conditions and
regularly screened for infections according to FELASA
protocols [15]. Mice were maintained on a 12 h light/dark
cycle and given ad libitum access to food and water. All
animals were acclimated for at least 1 week before surgery.
All efforts were made to minimize the number and suffer-
ing of animals used. All experimental procedures were
approved by the respective official committees (Charité-
Universitätsmedizin Berlin and governmental regulatory
authority of the federal state) and carried out in strict
accordance with the Animal Welfare Act, the European
Communities Council Directive of November 24, 1986
(86/609/EEC) and the ARRIVE (Animals in Research:
Reporting In Vivo Experiments) guidelines [16].
Model of cerebral ischemia
Mice were subjected to 30 min left filamentous middle
cerebral artery occlusion/ reperfusion as described in
detail previously [17–19].
Magnetic resonance imaging
T2-weighted images at 7 T (Pharmascan; Bruker Bios-
pin, Ettlingen, Germany) were obtained using a fat sup-
pressed two-dimensional turbo spin-echo sequence
(repetition time: 5109 msec; echo time: 65.2 msec). A
2 × 2 cm field of view, a 128 × 128 matrix, an in-plane
resolution of 156 μm, and a slice thickness of 0.4 mm
with no interslice distance were realized [18]. Data ac-
quisition and image processing were carried out with the
Bruker software Paravision 4.0. Calculation of lesion vol-
ume was carried out with Analyze 10.0 (AnalyzeDirect,
Inc.; Lenexa USA). The hyperintense ischemic areas in
T2-weighted images were assigned with a region of
interest tool. This enables a threshold-based segmenta-
tion by connecting all pixels within a specified threshold
range about the selected seed pixel and results in a 3D
object map of the whole stroke region. The total volume
of the whole object map was automatically calculated.
Immunohistochemistry and immunofluorescence
All procedures have been described in detail previously
[20]. Briefly, after an overdose of anesthetics, animals were
transcardially perfused with physiological saline followed
by 4 % PFA in 0.1 M phosphate buffer, pH 7.4. Brains were
dissected from the skulls and postfixed overnight. Before
sectioning from a dry ice-cooled copper block on a sliding
microtome (Leica), brains were transferred to 30 % su-
crose in 0.1 M phosphate buffer, pH 7.4. Brains were cut
in the coronal plane in 40 μm thick sections. Sections
were stained free floating. Immunohistochemistry
followed the peroxidase method with a biotinylated sec-
ondary antibody (1:500; Jackson ImmunoResearch La-
boratories, West Grove, PA), ABC Elite reagent (Vector
Laboratories, Burlingame, CA) and diaminobenzidine
(DAB; Sigma) as chromogen. For immunofluorescence,
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FITC- and RhodX-conjugated secondary antibodies (Jack-
son ImmunoResearch Laboratories, West Grove, PA) were
all used at a concentration of 1:250. Primary antibodies
were applied in the following concentrations: anti-NeuN
(mouse, 1:100; Chemicon, Temecula, CA), anti-desmin
(mouse, 1:100, #6322, Abcam), anti-Glucose Transporter-
1 (anti-Glut-1; rabbit, 1:100, #400060, Calbiochem).
Confocal microscopy
Confocal laser scanning microscopy was performed using
a spectral confocal microscope (LSM 700, Zeiss). Appro-
priate gain and black level settings were determined on
control slices stained with secondary antibodies alone.
Density of perfused vessels
Measurements followed a previously published protocol
[21]. Briefly, endovascular dye Evans blue (Sigma-Aldrich;
2 % in saline) was administered intravenously and allowed
to circulate for 5 min. Animals were decapitated and brains
cut into 10 μm coronal cryostat sections and digitized with
a cooled CCD-camera (CoolSNAP EZ, Photometrics,
Tucson, AZ) which was attached to a fluorescence micro-
scope. Images of whole brain sections at microscopic reso-
lution were obtained by joining together single camera
images using tiled-field mapping software (MCID Elite,
InterFocus, Mering, Germany) [21, 22].
Measurement of cerebral blood flow
Regional absolute cerebral blood flow (CBF) was quanti-
fied using the 14C-iodoantipyrine technique as described
in detail previously [23].
Dissection of brain tissue
For the molecular analyses, a 4 mm coronal section was
dissected from the left (i.e. ischemic) hemisphere (ap-
proximately from +5.8 mm to +1.8 mm from interaural
line) and stored at -80 °C until further use.
mRNA isolation and polymerase chain reactions
Tissue was homogenized and total RNA extracted using
TRIZOL Reagent (Invitrogen, Karlsruhe). For PCR amp-
lification, we used gene-specific primers (Table 1) and
Light Cycler FastStart DNA Master SYBR Green I
(Roche Diagnostics, Mannheim). PCR conditions were
as follows: preincubation 95 ° C, 10 min; 95 ° C, 15 s,
primer specific annealing temperature, 10 s, 72 ° C, 15 s
(45 cycles). Crossing points of amplified products were
determined using the Second Derivative Maximum
Method (Light Cycler Version 3.5, Roche). Quantifica-
tion of mRNA expression was relative to tripeptidyl pep-
tidase (Tpp) 2 [24]. Specificity of PCR products was
checked using melting curve analysis and electrophoresis
in a 1.5 % agarose gel.
Statistical analysis
Experiments were carried out in a blinded fashion. Data
are presented as means ± S.E.M. Unless otherwise indi-
cated, groups were compared by analysis of variance
(ANOVA) with level of significance set at 0.05 and two-
tailed p values.
Results
Expression of adhesion molecules after brain ischemia
First, we measured mRNA expression of VE- and N-
cadherin in ischemic brain tissue of wildtype and VE-
cadherin heterozygous mice in the sham condition as well
as at different time points after 30 min MCAo/reperfu-
sion. Note that VE-cadherin mRNA levels are markedly
reduced, but by no means completely depleted, in VEC+/-
mice (Fig. 1a). In both wildtype and VEC+/- mice, VE-
cadherin mRNA levels rose transiently shortly after brain
ischemia (Fig. 1a). Interestingly, the mRNA expression of
N-cadherin, showed a delayed upregulation after MCAo.
This effect was significantly increased in VEC+/- mice
compared to the wildtype mice at 72 h (Fig. 1b).
Expression of junctional molecules after brain ischemia is
influenced by VE-cadherin
Furthermore, the mRNA expression of key junctional
molecules occludin, claudin-5, α-catenin and β-catenin
was assessed. Again, the mRNA expression of these
junctional molecules showed a delayed, yet sustained
upregulation after MCAo. This effect was generally more
pronounced in VEC+/- mice (Fig. 2a-d).
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Partial loss of VE-cadherin alters the response of pericyte-
associated molecular signatures to brain ischemia
Pericytes are commonly identified by a combination
of molecular markers such as α-smooth muscle actin
(α-SMA), aminopeptidase N (CD13), and platelet-
derived growth factor receptor β (PDGFR-β). Overall, we
found a pattern characterized by increased ischemia-
induced mRNA transcription of pericyte-related mole-
cules in VEC+/- mice (Fig. 3a-c). Remarkably, CD13
mRNA levels in VEC+/- mice remained strongly elevated
even four weeks after MCAo, whereas in wildtype mice,
transcription of CD13 reverted back to baseline
Fig. 1 Expression of adhesion molecules after 30 min MCAo/reperfusion. Experiments investigating mRNA expression (also Figs. 2 and 3 a, b, c)
were performed in the same animals. Briefly, mRNA expression of VE-cadherin (a) and N-cadherin (b) was measured in ischemic brain tissue of
wildtype and VE-cadherin heterozygous mice after 30 min MCAo/reperfusion or sham operation. 2 VEC+/+ mice and 2 VEC+/- animals assigned
to the 72 h group died. Furthermore, 3 VEC+/+ and 5 VEC+/- mice assigned to the 28 d group died. The resultant group sizes were as
follows: 3 VEC+/+ sham, 3 VEC+/- sham, 4 VEC+/+ 6 h, 4 VEC+/- 6 h, 4 VEC+/+ 72 h, 4 VEC+/- 72 h, 6 VEC+/+ 28 d, 4 VEC+/- 28 d. Relative
mRNA expression is reported as the value normalized to tripeptidyl peptidase 2 (Tpp2) for each sample. One-way ANOVA, *p < 0.05 versus
sham, #p < 0.05 between genotypes within time point
Fig. 2 Expression of junctional molecules after brain ischemia is influenced by VE-cadherin (a-d) mRNA expression of key junctional molecules
occludin, claudin-5, α-catenin and β-catenin was assessed in ischemic brain tissue of wildtype and VE-cadherin heterozygous mice after 30 min
MCAo/reperfusion or sham operation. Relative mRNA expression is described as the value normalized to tripeptidyl peptidase 2 (Tpp2) for each
sample. N = 3-6 animals per group. One-way ANOVA, *p < 0.05 versus sham, #p < 0.05 between genotypes within time point
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concentrations (Fig. 3b). Based on these findings, desmin
immunoreactivity was used to visualize pericyte coverage
of Glut-1 expressing endothelial cells (Fig. 3d) in the
ischemic MCA territory [25]. In line with the mRNA
data, pericyte coverage in VEC+/- mice was noticeably
increased.
Absolute cerebral blood flow in ischemic striatum is
elevated in VEC+/- mice at four weeks after brain ischemia
Absolute cerebral blood flow (CBF) was measured at
four weeks after 30 min MCAo using the 14C-iodoanti-
pyrine tissue equilibration technique. Analysis of blood
flow was performed in the ipsilateral (i.e., ischemic) and
contralateral striatum. Surprisingly, absolute CBF in the
ischemic striatum of VEC+/- mice was significantly
higher than CBF in ischemic striatum of wildtype con-
trols (Fig. 4a, b). Physiological parameters including
body weight, mean arterial blood pressure, heart rate
and arterial blood gases did not differ between genotypes
(Table 2).
Partial loss of VE-cadherin does not affect neovascularization
at four weeks after MCAo
The density of perfused microvessels was quantified at
28 days after MCAo/reperfusion using endovascular Ev-
ans blue staining (Fig. 5a-d). The density of perfused
microvessels was significantly increased in ischemic as
compared to contralateral striatum. Furthermore, brain
ischemia led to alterations of microvascular structure in
ischemic brain tissue with significantly enlarged vessels.
However, in seeming contradiction to the results of
absolute CBF measurements described above, neither
vessel density nor mean vessel caliber differed signifi-
cantly between VEC+/- mice and wildtype controls.
Fig. 3 Expression of pericyte markers after 30 min MCAo/reperfusion. a-c mRNA transcription of pericyte-related molecules was measured in is-
chemic brain tissue of wildtype and VE-cadherin heterozygous mice after 30 min MCAo/reperfusion. Relative mRNA expression is reported as the
value normalized to tripeptidyl peptidase 2 (Tpp2) for each sample. N = 3-6 animals per group. One-way ANOVA, *p < 0.05 versus sham, #p < 0.05
between genotypes within time point. α-SMA (alpha-smooth muscle actin), CD13 (aminopeptidase N), PDGFR-β (platelet derived growth factor
receptor-β). d Increased pericyte coverage of vasculature in the ischemic brain of VEC+/- mice at 28 days after MCAo. Green: GLUT-1. Red: desmin.
Scale bar 50 μm
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Partial loss of VE-cadherin confers reduced lesion sizes at
four weeks after MCAo
Acute structural damage after brain ischemia was
assessed at 72 h using MR imaging (Fig. 6a, b). At this
early time point, lesion volumes were similar in VEC+/-
mice and wildtype controls. However, when chronic
stroke outcome was evaluated histologically on day 28, a
significant difference between genotypes with reduced
stroke volumes in VEC+/- mice had emerged (Fig. 6c, d).
Discussion
Stroke is a vascular disorder affecting neuronal function.
Notwithstanding, the bulk of experimental stroke re-
search has so far focussed rather one-sidedly on mecha-
nisms to salvage neuronal cells and may thus have
contributed to the apparent failure of bench-to-bedside
translation plaguing the field in recent years (e.g. [26]).
However, stroke affects different cell types in the brain,
which conjointly form the so-called ‘neurovascular unit’.
For instance, in the gray matter of the human cerebral
cortex, non-neuronal cells outnumber neurons by a
factor of approximately 1 to 2 [27]. In consequence,
brain ischemia impacts not only neurons but also astro-
cytes and other glial cells that support the neurons, the
axons of neurons that relay their signals to other cells,
and finally, and very importantly, the microvessels that
supply oxygen and nutrients to them. These consider-
ations provide a firm basis for shifting the previous focus
from neurons alone to the complex of neurons, micro-
vessels and supportive cells (astrocytes, pericytes and
resident inflammatory cells) reacting to brain ischemia.
Conceptually, the response of the neurovascular unit to
brain ischemia may be divided into two distinct phases:
(i) damage to the neurovascular unit during the acute
phase of stroke is followed by (ii) a phase of regeneration
and partial restoration of function. The detailed mecha-
nisms that govern this switch from early injury to
delayed recovery are still poorly understood.
Fig. 4 Measurement of absolute cerebral blood flow (CBF) in ischemic striatum. a CBF was measured in ischemic striatum (ipsi) and the
corresponding area of the contralateral hemisphere (contra) at four weeks after 30 min MCAo using the 14C-iodoantipyrine tissue equilibration
technique. The experiments depicted here as well as in Figs. 5 and 6a were conducted in the same animals. Briefly, of 10 VEC+/+ and 16 VEC+/-
mice entered into the experiment, 2 VEC+/+ and 5 VEC+/- mice died after MCAo. One further VEC+/+ mouse died during preparation for blood
flow experiments. Moreover, due to technical issues with the femoral artery catheter, one VEC+/+ and one VEC+/- animal each could not be used
for measurement of CBF. The analysis presented here is therefore based on 6 VEC+/+ and 10 VEC+/- mice. Finally, the ipsilateral side of the brain
of one further VEC+/- mouse sustained substantial damage during cryostat sectioning, so the ipsilateral hemisphere of this animal is also not
included here. Two-way ANOVA revealed an overall effect of factor ‘genotype’ on CBF. Newman-Keul’s post hoc test, *p < 0.05 between genotypes
within the ischemic striatum. Representative pseudocolored autoradiographic images of coronal brain sections are shown in (b). Scale bar in (b) 1 mm
Table 2 Physiological data
Weight (g) before MCAo Weigth (g) before CBF MABP (mmHg) Heart rate (n/min) pH pCO2 (mmHg) pO2 (mmHg)
WT 43.2 ± 1.7 41.9 ± 1.6 94 ± 1.7 366 ± 10 7.28 ± 0.02 42.7 ± 0.7 94.8 ± 2.0
VEC+/- 41.6 ± 0.9 38.8 ± 0.6 100.3 ± 2.3 391 ± 7.8 7.29 ± 0.01 44.1 ± 0.7 95.6 ± 1.3
Summary of physiological data obtained during CBF measurements. Weight (g) before MCAo: Body weights of all mice entered into the CBF experiments
(10 VEC+/+ and 16 VEC+/-). Weight (g) before CBF: Body weights of all mice which had survived up to this point (N = 8 VEC+/+ and 11 VEC+/- mice). MABP
(mmHg), heart rate (n/min), pH, pCO2 (mmHg), and pO2 (mmHg) were also assessed in 8 VEC+/+ mice and 11 VEC+/- mice. Please note that, following
physiological measurements, one VEC+/+ mouse died during preparation for blood flow experiments. Moreover, due to technical issues with the femoral
artery catheter, one VEC+/+ and one VEC+/- animal each could not be used for measurement of CBF (see legend to Fig. 4)
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Endothelial cells are a crucial component of the neuro-
vascular unit. Early on, endothelial cell injury results in
blood-brain barrier dysfunction, which favors tissue
swelling and may lead to intracerebral hemorrhage
after stroke (e.g. [28]). At later stages, the formation
of new vessels with altered morphology and micro-
vascular structure has been observed in ischemic
brain tissue [29].
Importantly, a number of studies, both by us and
others, have established the notion that vascular
Fig. 5 Neovascularization in ischemic striatum. Density (a) and mean caliber (b) of Evans blue-filled vessels were determined in ischemic striatum
(ipsi) and corresponding area of contralateral hemisphere (contra) using tiled-field mapping and computer-assisted image analysis. Representative
examples of Evans blue tiled-field images at low- (c) and high-power magnification (d). Note significant inducing effect of ischemia, but not of
genotype, on vessel density and mean vessel caliber in wildtype mice and in VEC+/- mice at four weeks after 30 min MCAo/reperfusion. The
experiments depicted here as well as in Figs. 4 and 6a were conducted in the same animals. Briefly, of 10 VEC+/+ and 16 VEC+/- mice entered into
the experiment, 2 VEC+/+ and 5 VEC+/- mice died after MCAo. One further VEC+/+ mouse died during preparation for blood flow experiments.
Finally, the ipsilateral side of the brain of one further VEC+/- mouse sustained substantial damage during cryostat sectioning, so this animal could
also not be included in this analysis. N = 7 VEC+/+ and n = 10 VEC+/- animals per group. Two-way ANOVA followed by Newman-Keul’s post hoc
test. *p < 0.05 relative to contralateral (i.e. non-ischemic) striatum within each genotype. Scale bar in (c) 1 mm (both images), scale bar in
(d) 200 μm (all four images)
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remodeling after stroke is a critical determinant of
chronic stroke outcome (e.g. [19, 21, 30, 31]).
This study yields a number of new and unexpected
insights into the vascular biology of ischemic stroke. In a
nutshell, we show that the N-cadherin/VE-cadherin
balance can be manipulated such that overall stroke out-
come is improved. Contrary to our initial assumption,
partial loss of VE-cadherin did not confer an increase in
acute lesion size at 72 h. However, none of the junc-
tional proteins investigated including VE-cadherin itself
showed a significant difference in mRNA expression
between genotypes at baseline. Furthermore, brains from
heterozygous mice appeared phenotypically normal, so
the genotypic differences were likely not large enough
to translate into an early phenotypic difference after
MCAo. Furthermore, we also did not detect signifi-
cant differences in microvessel densities or absolute
regional cerebral blood flow in the non-ischemic
contralateral hemispheres between VEC+/- mice and
wildtype controls.
More interestingly still, our results demonstrate that
reduced VE-cadherin expression leads to improved
vascular remodeling and a reduction in chronic lesion
sizes after stroke. In how far these beneficial effects
of reduced VE-cadherin expression also promote
functional rehabilitation after stroke (i.e. neuro-
Fig. 6 Acute and chronic lesion sizes. a, b The experiments depicted in Figs. 4 and 5 as well as here in Fig. 6a were conducted in the same
animals. Of 10 VEC+/+ and 16 VEC+/- mice entered into the experiment, 2 VEC+/+ and 4 VEC+/- mice died shortly after MCAo. a Acute neuronal
damage was assessed at 72 h after 30 min MCAo/reperfusion using 7 T MRI. One further VEC+/+ mouse had to be excluded because, due to
technical problems, MRI images in this animal were not of sufficient quality to allow a quantitative analysis. Therefore, the statistical evaluation
is based on 7 VEC+/+ and 12 VEC+/- mice. T-test, *p < 0.05 versus wildtype. Representative MR-images (T2) are given in (b). c, d Chronic stroke
outcome was assessed using NeuN immunohistochemistry. Direct cerebral lesion volumes (c) were determined on five coronal brain sections
(approximately interaural 6.6 mm, 5.3 mm, 3.9 mm, 1.9 mm and -0.1 mm) by computer-assisted volumetry. Here, of 10 VEC+/+ and 10 VEC+/- mice
entered into the experiment, 4 VEC+/+ and 3 VEC+/- survived to the time of histological analysis at four weeks after MCAo/reperfusion. T-test,
*p < 0.05 versus wildtype. Representative images of NeuN immunohistochemistry are presented in (d). Scale bar in (d) 500 μm
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behavioral assessment) lies beyond the scope of the
present work. The following points in particular, for
our purposes, merit further discussion here. Our find-
ing of increased N-cadherin and β-catenin mRNA
expression in VEC+/- mice after stroke recapitulates
earlier findings on endothelial cells in development,
where N-cadherin mRNA and protein expression was re-
duced by VE-cadherin via inhibition of β-catenin signaling
[14]. N-cadherin, in turn, recruits pericytes, which also
express N-cadherin, to endothelial cells [6, 14, 32].
Accordingly, we investigated mRNA transcription of a
panel of pericyte markers. Although not corroborated at
the protein level, we detected a compelling pattern of
elevated mRNA levels of pericyte-related molecules
after MCAo. On a related note, it is also worth men-
tioning that the density of perfused microvessels after
stroke did not differ between VEC+/- mice and wild-
type controls, but absolute cerebral blood flow did.
In line with these seemingly contradictory observa-
tions, an in vivo model of brain angiogenesis in the
absence of pericytes also yielded normal microvessel
density, but abnormalities in microvessel architecture
[33]. It has to be acknowledged that, for this investi-
gation, we did not assess CBF in separate sham con-
trols of either genotype but limited ourselves to the
analysis of blood flow in the contralateral striatum,
which served as an internal control. Brain ischemia
is a strong angiogenic stimulus [19, 21]. Our study of
post-stroke vascular remodeling thus reinforces
recent findings indicating that endothelial/pericyte
interactions are central processes in the regulation of
vessel formation, stabilization, remodeling, and func-
tion [34]. Importantly, pericytes are also beginning to
emerge as major regulators of cerebral blood flow
[35, 36]. Targeting endothelial/pericyte interactions
through junctional proteins may therefore provide a
new avenue for stroke treatment especially during
the subacute phase of recovery.
Conclusions
To summarize, our study reinforces accumulating evi-
dence that long-term stroke outcome depends critically
on vascular mechanisms and, in particular, cerebral
blood flow. Endothelial junctional proteins may be a
potent target for stroke treatment fostering regeneration
during the subacute phase of recovery.
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